Figure 6.

MOR-immunoreactivity in the dorsal horn of the spinal cord after vehicle, siRNA (to DOR) or mismatch (MM) RNA treatment. The MOR immunoreactivity is predominantly localized to laminae I/II of the dorsal horn. No significant difference in the immunoreactivity for MOR was seen among the 3 treatment groups. Tissue taken 72 hours after the last siRNA injection (siRNA recovery) also showed similar MOR immunoreactivity as the control groups. Each image is representative of multiple sections processed from 3 rats used in each group. The sections used in this figure and those used for DOR labeling shown in Figure 4 were from the same animals.